The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Interclox DC Intramammary Suspension

500, 250 mg/syringe Intramammary suspension


Main Information

Trade NameInterclox DC Intramammary Suspension
Active SubstancesCloxacillin
Strength500, 250 mg/syringe
Dosage FormIntramammary suspension
Licence HolderChem-Pharm
Licence NumberVPA10823/011/001

Group Information

ATC CodeQJ51RC Beta-lactam antibacterials, penicillins, combinations with other antibacterials
Therapeutic ClassAntibacterial


Licence Issued01/10/1999
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back